# MESS-study MRSA Eradication Study Skåne

> **NCT01269541** · NA · COMPLETED · sponsor: **Region Skane** · enrollment: 69 (actual)

## Conditions studied

- Throatcarriers of MRSA

## Interventions

- **DRUG:** Mupirocin
- **DRUG:** Rifampin+Clindamycine or Trimehoprimsulfa

## Key facts

- **NCT ID:** NCT01269541
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-01
- **Primary completion:** 2015-05-01
- **Final completion:** 2015-05-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269541, "MESS-study MRSA Eradication Study Skåne". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01269541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*